Unknown

Dataset Information

Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controls.


ABSTRACT:

Aims

Atrial fibrillation (AF) costs are expected to be substantial, but cost comparisons with the general population are scarce. Using data from the prospective Swiss-AF cohort study and population-based controls, we estimated the impact of AF on direct healthcare costs from the Swiss statutory health insurance perspective.

Methods

Swiss-AF patients, enrolled from 2014 to 2017, had documented, prevalent AF. We analysed 5 years of follow-up, where clinical data, and health insurance claims in 42% of the patients were collected on a yearly basis. Controls from a health insurance claims database were matched for demographics and region. The cost impact of AF was estimated using five different methods: (1) ordinary least square regression (OLS), (2) OLS-based two-part modelling,

SUBMITTER: Aebersold H 

PROVIDER: S-EPMC10503354 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature